Evofem Statements
EV
Data from Evofem`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Jun, 2023
Next reporting period:
28 Sep, 2023
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
12 Nov, 2024
Evofem Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2.458
-57.7 %
100
2.293
93.3
0.165
-96.3 %
6.7
0.402
16.4
7.099
288.8
7.501
-6.4 %
305.2
-7.336
-105 %
-298.5
-0.092
-3.7
-1.127
-45.9
-8.555
-263.9 %
-348.05
0.003
0.1
-8.558
-263.6 %
-348.2
-5.43
1.576
5.809
3109.4 %
100
1.376
23.7
4.433
2283.7 %
76.3
0.54
9.3
7.472
128.6
8.012
-32.4 %
137.9
-3.579
70.3 %
-61.6
1.546
26.6
-0.318
-5.5
-2.351
71.8 %
-40.5
0.003
0.05
-2.354
79.5 %
-40.5
-1.851
1.272
0.181
-97.2 %
100
0.384
212.2
-0.203
-104.3 %
-112.2
1.69
933.7
10.159
5612.7
11.849
-49.4 %
6546.4
-12.052
35.6 %
-6658.6
4.489
2480.1
-0.765
-422.7
-8.328
-109.3 %
-4601.1
0.008
4.4
-11.479
-112.8 %
-6342
-12.801
0.897
6.371
5.6 %
100
1.68
26.4
4.691
-1.2 %
73.6
5.207
81.7
18.208
285.8
23.415
-19.7 %
367.5
-18.724
23.3 %
-293.9
108.68
1705.8
-0.436
-6.8
89.519
171.1 %
1405.1
0.013
0.2
89.506
172.1 %
1404.9
135.72
0.659
6.034
—
100
1.285
21.3
4.749
—
78.7
7.744
128.3
21.424
355.1
29.168
—
483.4
-24.419
—
-404.7
-101.13
-1675.9
-0.415
-6.9
-125.96
—
-2087.5
0.02
0.3
-124.07
—
-2056.2
-4.573
27.13